Selected research
Market Outlook & Growth Opportunities
Global AAV Genome Sequencing Service Market Outlook and Growth Opportunities 2026
Market perspective
The global AAV Genome Sequencing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for AAV Genome Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for AAV Genome Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for AAV Genome Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the AAV Genome Sequencing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the AAV Genome Sequencing Service market include Azenta Life Sciences, Eurofins Genomics, Plasmidsaurus, Divergene, SeqCenter, Microsynth, CD Genomics, AccelevirDx and Avance Biosciences, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global AAV Genome Sequencing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of AAV Genome Sequencing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents AAV Genome Sequencing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AAV Genome Sequencing Service market.
AAV Genome Sequencing Service Segment by Company
Azenta Life Sciences
Eurofins Genomics
Plasmidsaurus
Divergene
SeqCenter
Microsynth
CD Genomics
AccelevirDx
Avance Biosciences
AAVnerGene
Merck
CIB DNA Core
PackGene Biotech
Creative Biolabs
Accelevir
AAV Genome Sequencing Service Segment by Type
Short-Read NGS Sequencing
Long-Read PacBio Sequencing
Nanopore Sequencing
AAV Genome Sequencing Service Segment by Application
Wild-Type AAV
Recombinant AAV (rAAV)
AAV Genome Sequencing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global AAV Genome Sequencing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the AAV Genome Sequencing Service key companies, revenue, market share, and recent developments.
3. To split the AAV Genome Sequencing Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions AAV Genome Sequencing Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify AAV Genome Sequencing Service significant trends, drivers, influence factors in global and regions.
6. To analyze AAV Genome Sequencing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AAV Genome Sequencing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AAV Genome Sequencing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AAV Genome Sequencing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AAV Genome Sequencing Service industry.
Chapter 3: Detailed analysis of AAV Genome Sequencing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of AAV Genome Sequencing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of AAV Genome Sequencing Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Short-Read NGS Sequencing
- Long-Read PacBio Sequencing
- Nanopore Sequencing
Applications
- Wild-Type AAV
- Recombinant AAV (rAAV)
Companies covered
- Azenta Life Sciences
- Eurofins Genomics
- Plasmidsaurus
- Divergene
- SeqCenter
- Microsynth
- CD Genomics
- AccelevirDx
- Avance Biosciences
- AAVnerGene
- Merck
- CIB DNA Core
- PackGene Biotech
- Creative Biolabs
- Accelevir
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global AAV Genome Sequencing Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global AAV Genome Sequencing Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 AAV Genome Sequencing Service Market Dynamics
- 2.1 AAV Genome Sequencing Service Industry Trends
- 2.2 AAV Genome Sequencing Service Industry Drivers
- 2.3 AAV Genome Sequencing Service Industry Opportunities and Challenges
- 2.4 AAV Genome Sequencing Service Industry Restraints
3 AAV Genome Sequencing Service Market by Company
- 3.1 Global AAV Genome Sequencing Service Company Revenue Ranking in 2025
- 3.2 Global AAV Genome Sequencing Service Revenue by Company (2021-2026)
- 3.3 Global AAV Genome Sequencing Service Company Ranking (2024-2026)
- 3.4 Global AAV Genome Sequencing Service Company Manufacturing Base and Headquarters
- 3.5 Global AAV Genome Sequencing Service Company Product Type and Application
- 3.6 Global AAV Genome Sequencing Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global AAV Genome Sequencing Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 AAV Genome Sequencing Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 AAV Genome Sequencing Service Market by Type
- 4.1 AAV Genome Sequencing Service Type Introduction
- 4.1.1 Short-Read NGS Sequencing
- 4.1.2 Long-Read PacBio Sequencing
- 4.1.3 Nanopore Sequencing
- 4.2 Global AAV Genome Sequencing Service Sales Value by Type
- 4.2.1 Global AAV Genome Sequencing Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global AAV Genome Sequencing Service Sales Value by Type (2021-2032)
- 4.2.3 Global AAV Genome Sequencing Service Sales Value Share by Type (2021-2032)
5 AAV Genome Sequencing Service Market by Application
- 5.1 AAV Genome Sequencing Service Application Introduction
- 5.1.1 Wild-Type AAV
- 5.1.2 Recombinant AAV (rAAV)
- 5.2 Global AAV Genome Sequencing Service Sales Value by Application
- 5.2.1 Global AAV Genome Sequencing Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global AAV Genome Sequencing Service Sales Value by Application (2021-2032)
- 5.2.3 Global AAV Genome Sequencing Service Sales Value Share by Application (2021-2032)
6 AAV Genome Sequencing Service Regional Value Analysis
- 6.1 Global AAV Genome Sequencing Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global AAV Genome Sequencing Service Sales Value by Region (2021-2032)
- 6.2.1 Global AAV Genome Sequencing Service Sales Value by Region: 2021-2026
- 6.2.2 Global AAV Genome Sequencing Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America AAV Genome Sequencing Service Sales Value (2021-2032)
- 6.3.2 North America AAV Genome Sequencing Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe AAV Genome Sequencing Service Sales Value (2021-2032)
- 6.4.2 Europe AAV Genome Sequencing Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific AAV Genome Sequencing Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific AAV Genome Sequencing Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America AAV Genome Sequencing Service Sales Value (2021-2032)
- 6.6.2 South America AAV Genome Sequencing Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa AAV Genome Sequencing Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa AAV Genome Sequencing Service Sales Value Share by Country, 2025 VS 2032
7 AAV Genome Sequencing Service Country-level Value Analysis
- 7.1 Global AAV Genome Sequencing Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global AAV Genome Sequencing Service Sales Value by Country (2021-2032)
- 7.2.1 Global AAV Genome Sequencing Service Sales Value by Country (2021-2026)
- 7.2.2 Global AAV Genome Sequencing Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA AAV Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA AAV Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA AAV Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada AAV Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada AAV Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada AAV Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico AAV Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico AAV Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico AAV Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany AAV Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany AAV Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany AAV Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France AAV Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France AAV Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France AAV Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. AAV Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. AAV Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. AAV Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy AAV Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy AAV Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy AAV Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain AAV Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain AAV Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain AAV Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia AAV Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia AAV Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia AAV Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands AAV Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands AAV Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands AAV Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries AAV Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries AAV Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries AAV Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China AAV Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China AAV Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China AAV Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan AAV Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan AAV Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan AAV Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea AAV Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea AAV Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea AAV Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India AAV Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India AAV Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India AAV Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia AAV Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia AAV Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia AAV Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia AAV Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia AAV Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia AAV Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil AAV Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil AAV Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil AAV Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina AAV Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina AAV Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina AAV Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile AAV Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile AAV Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile AAV Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia AAV Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia AAV Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia AAV Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru AAV Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru AAV Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru AAV Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia AAV Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia AAV Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia AAV Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel AAV Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel AAV Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel AAV Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE AAV Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE AAV Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE AAV Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey AAV Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey AAV Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey AAV Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran AAV Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran AAV Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran AAV Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt AAV Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt AAV Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt AAV Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Azenta Life Sciences
- 8.1.1 Azenta Life Sciences Company Information
- 8.1.2 Azenta Life Sciences Business Overview
- 8.1.3 Azenta Life Sciences AAV Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.1.4 Azenta Life Sciences AAV Genome Sequencing Service Product Portfolio
- 8.1.5 Azenta Life Sciences Recent Developments
- 8.2 Eurofins Genomics
- 8.2.1 Eurofins Genomics Company Information
- 8.2.2 Eurofins Genomics Business Overview
- 8.2.3 Eurofins Genomics AAV Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.2.4 Eurofins Genomics AAV Genome Sequencing Service Product Portfolio
- 8.2.5 Eurofins Genomics Recent Developments
- 8.3 Plasmidsaurus
- 8.3.1 Plasmidsaurus Company Information
- 8.3.2 Plasmidsaurus Business Overview
- 8.3.3 Plasmidsaurus AAV Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.3.4 Plasmidsaurus AAV Genome Sequencing Service Product Portfolio
- 8.3.5 Plasmidsaurus Recent Developments
- 8.4 Divergene
- 8.4.1 Divergene Company Information
- 8.4.2 Divergene Business Overview
- 8.4.3 Divergene AAV Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.4.4 Divergene AAV Genome Sequencing Service Product Portfolio
- 8.4.5 Divergene Recent Developments
- 8.5 SeqCenter
- 8.5.1 SeqCenter Company Information
- 8.5.2 SeqCenter Business Overview
- 8.5.3 SeqCenter AAV Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.5.4 SeqCenter AAV Genome Sequencing Service Product Portfolio
- 8.5.5 SeqCenter Recent Developments
- 8.6 Microsynth
- 8.6.1 Microsynth Company Information
- 8.6.2 Microsynth Business Overview
- 8.6.3 Microsynth AAV Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.6.4 Microsynth AAV Genome Sequencing Service Product Portfolio
- 8.6.5 Microsynth Recent Developments
- 8.7 CD Genomics
- 8.7.1 CD Genomics Company Information
- 8.7.2 CD Genomics Business Overview
- 8.7.3 CD Genomics AAV Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.7.4 CD Genomics AAV Genome Sequencing Service Product Portfolio
- 8.7.5 CD Genomics Recent Developments
- 8.8 AccelevirDx
- 8.8.1 AccelevirDx Company Information
- 8.8.2 AccelevirDx Business Overview
- 8.8.3 AccelevirDx AAV Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.8.4 AccelevirDx AAV Genome Sequencing Service Product Portfolio
- 8.8.5 AccelevirDx Recent Developments
- 8.9 Avance Biosciences
- 8.9.1 Avance Biosciences Company Information
- 8.9.2 Avance Biosciences Business Overview
- 8.9.3 Avance Biosciences AAV Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.9.4 Avance Biosciences AAV Genome Sequencing Service Product Portfolio
- 8.9.5 Avance Biosciences Recent Developments
- 8.10 AAVnerGene
- 8.10.1 AAVnerGene Company Information
- 8.10.2 AAVnerGene Business Overview
- 8.10.3 AAVnerGene AAV Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.10.4 AAVnerGene AAV Genome Sequencing Service Product Portfolio
- 8.10.5 AAVnerGene Recent Developments
- 8.11 Merck
- 8.11.1 Merck Company Information
- 8.11.2 Merck Business Overview
- 8.11.3 Merck AAV Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.11.4 Merck AAV Genome Sequencing Service Product Portfolio
- 8.11.5 Merck Recent Developments
- 8.12 CIB DNA Core
- 8.12.1 CIB DNA Core Company Information
- 8.12.2 CIB DNA Core Business Overview
- 8.12.3 CIB DNA Core AAV Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.12.4 CIB DNA Core AAV Genome Sequencing Service Product Portfolio
- 8.12.5 CIB DNA Core Recent Developments
- 8.13 PackGene Biotech
- 8.13.1 PackGene Biotech Company Information
- 8.13.2 PackGene Biotech Business Overview
- 8.13.3 PackGene Biotech AAV Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.13.4 PackGene Biotech AAV Genome Sequencing Service Product Portfolio
- 8.13.5 PackGene Biotech Recent Developments
- 8.14 Creative Biolabs
- 8.14.1 Creative Biolabs Company Information
- 8.14.2 Creative Biolabs Business Overview
- 8.14.3 Creative Biolabs AAV Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.14.4 Creative Biolabs AAV Genome Sequencing Service Product Portfolio
- 8.14.5 Creative Biolabs Recent Developments
- 8.15 Accelevir
- 8.15.1 Accelevir Company Information
- 8.15.2 Accelevir Business Overview
- 8.15.3 Accelevir AAV Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.15.4 Accelevir AAV Genome Sequencing Service Product Portfolio
- 8.15.5 Accelevir Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst